Shining a light on drug discovery
FAR Biotech was founded by Dr. Martin Martinov in 2016 after more than two decades in academia and industry refining the computational modeling of quantum mechanical interactions.
We named our company after the Bulgarian word “far” for “lighthouse” or “beacon”. FAR seeks to shine a light on drug discovery in areas of high unmet clinical need. We explore search spaces that other approaches would not investigate — to identify novel chemical structures against hard-to-drug targets.
who we are
We are a computational drug discovery company that is building a portfolio of superior preclinical assets against hard-to-drug targets with high unmet need. We utilize proprietary technology for multi-property optimization of unique, structurally novel candidate compounds. Our proprietary, target-agnostic approach has been validated across a number of diverse therapeutic areas.
OUR methodology
Quantum mechanics is core to our discovery process.
Our Quantum Biomodeling approach embodies a complete and rigorous application of (non-relativistic) quantum mechanics, which accurately describes physical structures in quantum space, allowing us to identify the quantum pharmacophore — the bioactive part of a molecule in quantum space. This is what sets us apart and allows us to deliver compounds optimized with the desired pharmacological properties in a relatively short time.
partnerships
We enter into collaborations with research organizations who bring experimental capabilities as well as the expertise and infrastructure required to get drugs to market.